1.

Vimentin prevents a miR-dependent negative regulation of tissue factor mRNA during epithelial-mesenchymal transitions and facilitates early metastasis ; Belgique

2.

Vimentin prevents a miR-dependent negative regulation of tissue factor mRNA during epithelial-mesenchymal transitions and facilitates early metastasis ; Belgique

1.

Attitudes towards booster, testing and isolation, and their impact on COVID-19 response in winter 2022/2023 in France, Belgium, and Italy: a cross-sectional survey and modeling stu...

2.

Attitudes towards booster, testing and isolation, and their impact on COVID-19 response in winter 2022/2023 in France, Belgium, and Italy: a cross-sectional survey and modeling stu...

3.

Attitudes towards booster, testing and isolation, and their impact on COVID-19 response in winter 2022/2023 in France, Belgium, and Italy: a cross-sectional survey and modeling stu...

4.

Attitudes towards booster, testing and isolation, and their impact on COVID-19 response in winter 2022/2023 in France, Belgium, and Italy: a cross-sectional survey and modeling stu...

5.

Attitudes towards booster, testing and isolation, and their impact on COVID-19 response in winter 2022/2023 in France, Belgium, and Italy: a cross-sectional survey and modeling stu...

1.

Curative effect of second curettage for treatment of gestational trophoblastic disease - Results of the Belgian registry for gestational trophoblastic disease.

2.

Curative effect of second curettage for treatment of gestational trophoblastic disease - Results of the Belgian registry for gestational trophoblastic disease.

3.

Curative effect of second curettage for treatment of gestational trophoblastic disease - Results of the Belgian registry for gestational trophoblastic disease.

4.

Curative effect of second curettage for treatment of gestational trophoblastic disease - Results of the Belgian registry for gestational trophoblastic disease.

5.

Curative effect of second curettage for treatment of gestational trophoblastic disease - Results of the Belgian registry for gestational trophoblastic disease.

6.

Curative effect of second curettage for treatment of gestational trophoblastic disease - Results of the Belgian registry for gestational trophoblastic disease.

7.

Curative effect of second curettage for treatment of gestational trophoblastic disease - Results of the Belgian registry for gestational trophoblastic disease.

8.

Curative effect of second curettage for treatment of gestational trophoblastic disease - Results of the Belgian registry for gestational trophoblastic disease.

9.

Curative effect of second curettage for treatment of gestational trophoblastic disease - Results of the Belgian registry for gestational trophoblastic disease.

1.

FCGG Renal Biopsy Network: first epidemiological report on pediatric renal disease in Flanders

2.

FCGG Renal Biopsy Network: first epidemiological report on pediatric renal disease in Flanders

1.

Conformational Changes Induced by the A21G Flemish Mutation in the Amyloid Precursor Protein Lead to Increased Aβ Production

2.

Conformational Changes Induced by the A21G Flemish Mutation in the Amyloid Precursor Protein Lead to Increased Aβ Production

1.

Prevalence of multidrug-resistant organisms in nursing homes in Belgium in 2015.

2.

Prevalence of multidrug-resistant organisms in nursing homes in Belgium in 2015.

3.

Prevalence of multidrug-resistant organisms in nursing homes in Belgium in 2015.

4.

Prevalence of multidrug-resistant organisms in nursing homes in Belgium in 2015.

5.

Prevalence of multidrug-resistant organisms in nursing homes in Belgium in 2015.

6.

Prevalence of multidrug-resistant organisms in nursing homes in Belgium in 2015.

7.

Prevalence of multidrug-resistant organisms in nursing homes in Belgium in 2015.

8.

Prevalence of multidrug-resistant organisms in nursing homes in Belgium in 2015.

1.

Prevalence of multidrug-resistant organisms in nursing homes in Belgium in 2015

2.

Prevalence of multidrug-resistant organisms in nursing homes in Belgium in 2015

3.

Prevalence of multidrug-resistant organisms in nursing homes in Belgium in 2015

4.

Prevalence of multidrug-resistant organisms in nursing homes in Belgium in 2015

5.

Prevalence of multidrug-resistant organisms in nursing homes in Belgium in 2015

6.

Prevalence of multidrug-resistant organisms in nursing homes in Belgium in 2015

7.

Prevalence of multidrug-resistant organisms in nursing homes in Belgium in 2015

8.

Prevalence of multidrug-resistant organisms in nursing homes in Belgium in 2015

1.

The implications of K-Ar glauconite dating of the Diest Formation on the paleogeography of the Upper Miocene in Belgium

2.

The implications of K-Ar glauconite dating of the Diest Formation on the paleogeography of the Upper Miocene in Belgium

1.

Importance of pathological review of gestational trophoblastic diseases: results of the Belgian Gestational Trophoblastic Diseases Registry.

2.

Importance of pathological review of gestational trophoblastic diseases: results of the Belgian Gestational Trophoblastic Diseases Registry.

3.

Importance of pathological review of gestational trophoblastic diseases: results of the Belgian Gestational Trophoblastic Diseases Registry.

4.

Importance of pathological review of gestational trophoblastic diseases: results of the Belgian Gestational Trophoblastic Diseases Registry.

5.

Importance of pathological review of gestational trophoblastic diseases: results of the Belgian Gestational Trophoblastic Diseases Registry.

6.

Importance of pathological review of gestational trophoblastic diseases: results of the Belgian Gestational Trophoblastic Diseases Registry.

1.

Comparison of the RGM medium and the mycobacterial growth indicator tube automated system for isolation of non-tuberculous mycobacteria from sputum samples of cystic fibrosis patie...

2.

Comparison of the RGM medium and the mycobacterial growth indicator tube automated system for isolation of non-tuberculous mycobacteria from sputum samples of cystic fibrosis patie...

3.

Comparison of the RGM medium and the mycobacterial growth indicator tube automated system for isolation of non-tuberculous mycobacteria from sputum samples of cystic fibrosis patie...

4.

Comparison of the RGM medium and the mycobacterial growth indicator tube automated system for isolation of non-tuberculous mycobacteria from sputum samples of cystic fibrosis patie...

5.

Comparison of the RGM medium and the mycobacterial growth indicator tube automated system for isolation of non-tuberculous mycobacteria from sputum samples of cystic fibrosis patie...

6.

Comparison of the RGM medium and the mycobacterial growth indicator tube automated system for isolation of non-tuberculous mycobacteria from sputum samples of cystic fibrosis patie...